The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
The Thyroid Epidemiology, Audit, and Research Study (TEARS): Morbidity in Patients with Endogenous Subclinical Hyperthyroidism
Abstract
OBJECTIVE: Our objective was to investigate the long-term outcomes for patients with endogenous subclinical hyperthyroidism (SH). DESIGN: Population record-linkage technology was used retrospectively to identify patients with SH and hospital admissions from January 1, 1993, to December 31, 2009. PATIENTS: All Tayside residents over 18 yr old with at least two serum TSH measurements below the reference range for at least 4 months apart and normal free T(4)/total T(4) and normal total T(3) concentrations at baseline were included as potential cases. Using a unique patient identifier, data linkage enabled a cohort of SH cases to be identified from biochemistry, prescription, admission, and radioactive iodine treatment records matched to five comparators from the general population. OUTCOME MEASURES: The association between endogenous SH and cardiovascular disease, fracture, dysrhythmia, dementia, and cancer was assessed. RESULTS: Compared with the reference population, SH was associated with an increased risk of nonfatal cardiovascular morbidity, osteoporotic fracture, dysrhythmia, and dementia, with adjusted hazard ratios (HR) of 1.39 (1.22-1.58), 1.25 (1.04-1.50), 1.65 (1.26-2.17), and 1.64 (1.20-2.25), respectively. When SH patients who developed overt hyperthyroidism during follow-up were excluded, SH patients were associated with an increased risk of cardiovascular morbidity [HR = 1.36 (1.19-1.57)], dysrhythmia [HR = 1.39 (1.02-1.90)], and dementia [HR = 1.79 (1.28-2.51)] but not fracture and cancer. CONCLUSION: Patients with endogenous SH have an increased risk of cardiovascular disease and dysrhythmia. There is an association with fracture and dementia that is not related to TSH concentration and therefore is less likely to be causally related. No association was found between SH and cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In TEARS, SHyper was associated with an increased risk of fractures that was not related to TSH concentration [63] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [63]
In the citing paper
“Conflicting results have also been reported regarding the risk of fractures [63,105,106] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [63]
In the citing paper
“The risk of dementia, although increased in Endo SHyper, was not related to TSH concentration in the Thyroid Epidemiology, Audit and Research Study (TEARS), suggesting that it was not causally related [63] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [63]
In the citing paper
“Similarly, in a large retrospective case-control study, which was not included in the metaanalysis by Collet et al., an association between SHyper and increased risk of arrhythmia was reported in patients with grade 2 SHyper [63] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [63]
In the citing paper
“Some of these studies, including the meta-analyses, have also examined nonfatal cardiovascular events in SH, with similar increased risks (383,388,390,391).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [391]
In the citing paper
“A number of population-based studies have reported that certain groups of subjects with SH have increased fracture rates, including all adults (407), postmenopausal women (408), men (409), or subjects who progress to overt hyperthyroidism over time (391).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [391]
In the citing paper
“Sawin et al. (399) first reported a 2.8-fold increased risk of atrial fibrillation in SH subjects over age 60 years in 1994, and subsequent studies have confirmed that the risk of arrhythmias, particularly atrial fibrillation, is increased in SH (381,384,388,391,400,401).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [391]
In the citing paper
“Some of these studies re-ported increased risks of overall mortality in older subjects (380,429), cardiovascular events (391), heart failure (381), and atrial fibrillation in all subjects (401) or in older subjects (384), and vertebral fractures in older women (408).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [391]
Citations
Cites
The Colorado Thyroid Disease Prevalence Study
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.526 · Cited by 2,824
Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons
Sawin, C. T., Geller, A., Wolf, P. A., Belanger, A. J., Baker, E., Bacharach, P., Wilson, P., Benjamin, E. J., & D'Agostino, R. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311901 · Cited by 1,259
Thyroid Status, Disability and Cognitive Function, and Survival in Old Age
Gussekloo, J. (2004) · JAMA · doi:10.1001/jama.292.21.2591 · Cited by 899
Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults
Cappola, A. R., Fried, L. P., Arnold, A. M., Danese, M. D., Kuller, L. H., Burke, G. L., Tracy, R. P., & Ladenson, P. W. (2006) · JAMA · doi:10.1001/jama.295.9.1033 · Cited by 862
Parle, J. V., Maisonneuve, P., Sheppard, M. C., Boyle, P., & Franklyn, J. A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06067-6 · Cited by 669
Subclinical thyroid dysfunction as a risk factor for cardiovascular disease
Walsh, J. P., Bremner, A. P., Bulsara, M. K., O’Leary, P., Leedman, P. J., Feddema, P., & Michelangeli, V. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2467 · Cited by 536
THE EPIDEMIOLOGY OF THYROID DISEASE AND IMPLICATIONS FOR SCREENING
Wang, C., & Crapo, L. M. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70240-1 · Cited by 520
Meta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality
Ochs, N., Auer, R., Bauer, D. C., Nanchen, D., Gussekloo, J., Cornuz, J., & Rodondi, N. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-11-200806030-00225 · Cited by 477
Faber, J., & Galløe, A. M. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1300350 · Cited by 377
Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study
Kalmijn, S., Mehta, K. M., Pols, H. A. P., Albert Hofman, D., Drexhage, H. A., & Breteler, M. M. B. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01146.x · Cited by 319
Thyroid hormone in health and disease
Boelaert, K., & Franklyn, J. A. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06131 · Cited by 287
The thyroid epidemiology, audit, and research study: thyroid dysfunction in the general population
Flynn, R. W. V., MacDonald, T. M., Morris, A. D., Jung, R. T., & Leese, G. P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032089 · Cited by 196
Self-citationFöldes, J., Tarján, G., Szathmari, M., Varga, F., Krasznai, I., & Horvath, C. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02403.x · Cited by 170
Murphy, E., & Williams, G. R. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02053.x · Cited by 160
Mortality and Vascular Outcomes in Patients Treated for Thyroid Dysfunction
Flynn, R. W. V., MacDonald, T. M., Jung, R. T., Morris, A. D., & Leese, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1833 · Cited by 136
Self-citationLeese, G., Jung, R. T., Guthrie, C., Waugh, N. R., & Browning, M. C. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb01480.x · Cited by 131
Self-citationVadiveloo, T., Donnan, P. T., Cochrane, L., & Leese, G. P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0854 · Cited by 118
Self-citationLow Thyrotropin Levels Are Not Associated with Bone Loss in Older Women: A Prospective Study
Bauer, D. C., Nevitt, M. C., Ettinger, B. B., & Stone, K. L. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4229 · Cited by 99
Subclinical hyperthyroidism and dementia: the Sao Paulo Ageing & Health Study (SPAH)
Benseñor, I. M., Lotufo, P. A., Menezes, P. R., & Scazufca, M. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-298 · Cited by 72
Thyroid Hormone Use, Hyperthyroidism and Mortality in Older Women
Bauer, D. C., Rodondi, N., Stone, K. L., & Hillier, T. A. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.04.034 · Cited by 71
Flagged first, then by citations
Cited by
Sorted by citations
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
“Some of these studies reported increased risks of overall mortality in older subjects (380,429), cardiovascular events (391), heart failure (381), and atrial fibrillation in all subjects (401) or in older subjects (384), and vertebral fractures in older women (408).”
BackgroundResultInfluentialCooper, D. S., & Biondi, B. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60276-6 · Cited by 1,039
Thyroid hormones and cardiovascular disease
Jabbar, A., Pingitore, A., Pearce, S. H. S., Zaman, A., Iervasi, G., & Razvi, S. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.174 · Cited by 729
Subclinical hyperthyroidism and the risk of coronary heart disease and mortality
Collet, T.-H., Gussekloo, J., Bauer, D. C., den Elzen, W. P. J., Cappola, A. R., Balmer, P., Iervasi, G., Åsvold, B. O., Sgarbi, J. A., Völzke, H., et al. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.402 · Cited by 572
Role of Thyroid Hormones in Skeletal Development and Bone Maintenance
Bassett, J. H. D., & Williams, G. R. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1106 · Cited by 540
Metadata
- Authors
- Vadiveloo, T., Donnan, P. T., Cochrane, L., & Leese, G. P.
- Affiliations
- University of Dundee (GB)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-05
- Volume
- 96
- Issue
- 5
- Pages
- 1344-1351
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2163166383
- Cited by
- 186
- References
- 20
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 14 · 2023: 7 · 2022: 8 · 2021: 11 · 2020: 12 · 2019: 17 · 2018: 14 · 2017: 14 · 2016: 19 · 2015: 11 · 2014: 10 · 2013: 12 · 2012: 21
- FWCI
- 12.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- Funders
- GlaxoSmithKline
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- subclinical hyperthyroidism, cardiovascular morbidity, cardiac arrhythmias, osteoporotic fractures, dementia, cancer risk, overt hyperthyroidism, thyroid-stimulating hormone, long-term outcomes, thyroid dysfunction
- MeSH terms
- Age Factors, Aged, Arrhythmias, Cardiac, Cardiovascular Diseases, Dementia, Female, Follow-Up Studies, Humans, Hyperthyroidism, Male, Middle Aged, Neoplasms, Osteoporosis, Scotland, Sex Factors, Thyroid Hormones, Thyrotropin, Databases, Factual, Treatment Outcome, Risk Assessment, Fractures, Bone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
